2023 - Research.com Medicine in Belgium Leader Award
2023 - Research.com Biology and Biochemistry in Belgium Leader Award
Her primary areas of investigation include Angiogenesis, Matrix metalloproteinase, Cell biology, Cancer research and Immunology. Her biological study spans a wide range of topics, including Vascular endothelial growth factor A, Vascular endothelial growth factor, Tumor progression and In vivo. Her Matrix metalloproteinase research is multidisciplinary, incorporating elements of Inflammation, Respiratory disease, Extracellular matrix and Pathology.
Her Cell biology research includes themes of Proteases, Plasmin, Fibroblast growth factor receptor and Cell growth. Her Cancer research research is multidisciplinary, incorporating perspectives in Cancer cell, Molecular biology, Growth factor and Vimentin. Agnès Noël has researched Immunology in several fields, including Mesenchymal stem cell and Bronchoalveolar lavage, Lung.
Agnès Noël mainly investigates Cancer research, Angiogenesis, Internal medicine, Matrix metalloproteinase and Cell biology. Her research investigates the connection between Cancer research and topics such as Cancer cell that intersect with issues in Stromal cell. Agnès Noël works mostly in the field of Angiogenesis, limiting it down to topics relating to In vivo and, in certain cases, In vitro.
Her research integrates issues of Estetrol, Endocrinology and Oncology in her study of Internal medicine. Her research in Matrix metalloproteinase tackles topics such as Molecular biology which are related to areas like Cell culture. She is interested in Extracellular matrix, which is a branch of Cell biology.
Her primary scientific interests are in Cancer research, Internal medicine, Angiogenesis, Lymphangiogenesis and Metastasis. She combines subjects such as Cancer cell, Cancer, Breast cancer and Pleural mesothelioma with her study of Cancer research. Her Internal medicine study combines topics in areas such as Estetrol, Endocrinology and Oncology.
Her Angiogenesis research incorporates themes from Inflammation and Extracellular matrix, Cell biology. Her Lymphangiogenesis study combines topics from a wide range of disciplines, such as Vascular endothelial growth factor C, Receptor and Lymphatic system, Pathology. Her Pathology study integrates concerns from other disciplines, such as Anatomy and In vivo.
Her main research concerns Cancer research, In vivo, Lymphangiogenesis, Angiogenesis and Lymphatic system. Her work carried out in the field of Cancer research brings together such families of science as Cancer cell, Downregulation and upregulation, Small hairpin RNA, Metastasis and Breast cancer. The various areas that Agnès Noël examines in her In vivo study include EGFR inhibitors, Internal medicine, Epirubicin and Endocrinology.
Her Lymphangiogenesis research includes elements of Vascular endothelial growth factor C and Pathology. Her Angiogenesis study incorporates themes from Extracellular matrix and Cell biology. The Extracellular matrix study combines topics in areas such as Tumor microenvironment, Cancer, Inflammation, Matrix metalloproteinase and Internalization.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
Peter Carmeliet;Lieve Moons;Aernout Luttun;Valeria Vincenti.
Nature Medicine (2001)
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
Khalid Bajou;Agnès Noël;R. D. Gerard;Véronique Masson.
Nature Medicine (1998)
Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences
Vassilis Tsatsaris;Frederic Goffin;Carine Munaut;Jean-François Brichant.
The Journal of Clinical Endocrinology and Metabolism (2003)
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Julie Halkein;Sebastien P. Tabruyn;Melanie Ricke-Hoch;Arash Haghikia.
Journal of Clinical Investigation (2013)
Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
Carine Munaut;Agnès Noël;Olivier Hougrand;Jean-Michel Foidart.
International Journal of Cancer (2003)
The Plasminogen Activator Inhibitor PAI-1 Controls In Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies
Khalid Bajou;Véronique Masson;Robert D. Gerard;Petra M. Schmitt.
Journal of Cell Biology (2001)
Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization
Jean-Marie Rakic;Vincent Lambert;Laetitia Devy;Aernout Luttun.
Investigative Ophthalmology & Visual Science (2003)
Consensus guidelines for the use and interpretation of angiogenesis assays
Patrycja Nowak-Sliwinska;Kari Alitalo;Elizabeth Allen;Andrey Anisimov.
In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy.
Régis Masson;Olivier Lefebvre;Agnès Noël;Mostapha El Fahime.
Journal of Cell Biology (1998)
MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression
Nor Eddine Sounni;L. Devy;A. Hajitou;Francis Frankenne.
The FASEB Journal (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: